Skip to main content
Livermore
Livermore
ZHEN

Latest Form 144 filings

Officers, directors and other affiliates of a company file Form 144 when they place an order to sell restricted or control shares, if they plan to sell more than 5,000 shares or more than $50,000 worth within three months. It is a notice of a planned sale; officers and directors report the sale itself later on Form 4. 13D, 13G and Form 144 explained

Form 144 notices

Newest first. When a Form 144/A amends a notice, only the amendment is listed.

Filed in the last 365 days (US Eastern dates).

Form 144 filings on Livermore: Jan 4, 2023 to Oct 5, 2026.

Notices with a clearly misreported market value are left out of this list and its totals; they still appear, flagged, on the company's page. A value counts as misreported when the price per share it implies is far above the company's prices in Form 4 trades and 13F filings around the planned sale date.

Notices
68
Market value to sell
$49.1M
Sellers
14
Companies
7
Under 10b5-1 plans
19
Form 144 filings
CompanyFiled (ET)SellerShares to sellMarket valuePlanned saleBrokerFiling
ANABAnaptysbio, IncJan 8, 20264:08 PM ETDennis MulroyOfficer1.91K$83.8KJan 7, 2026Morgan Stanley Smith Barney LLC Executive Financial ServicesSEC
ANABAnaptysbio, IncJan 7, 20264:06 PM ETEric J LoumeauOfficer7.62K$348.2KJan 7, 202610b5-1Morgan Stanley Smith Barney LLC Executive Financial ServicesSEC
ANABAnaptysbio, IncJan 6, 20269:07 PM ETDaniel FagaOfficer15.3K$688.1KJan 5, 2026Morgan Stanley Smith Barney LLC Executive Financial ServicesSEC
ANABAnaptysbio, IncJan 6, 20269:05 PM ETDennis MulroyOfficer3.36K$151.2KJan 5, 2026Morgan Stanley Smith Barney LLC Executive Financial ServicesSEC
ANABAnaptysbio, IncJan 6, 20269:04 PM ETPaul F. LizzulOfficer4.22K$189.6KJan 5, 2026Morgan Stanley Smith Barney LLC Executive Financial ServicesSEC
ANABAnaptysbio, IncJan 6, 20269:02 PM ETEric J LoumeauOfficer2.98K$134.1KJan 5, 2026Morgan Stanley Smith Barney LLC Executive Financial ServicesSEC
ANABAnaptysbio, IncDec 23, 20254:03 PM ETJoe Anthony WareDirector3.90K$193.3KDec 23, 2025Morgan Stanley Smith Barney LLC Executive Financial ServicesSEC
ANABAnaptysbio, IncDec 22, 20254:05 PM ETEric J LoumeauOfficer10.0K$510.0KDec 22, 202510b5-1Morgan Stanley Smith Barney LLC Executive Financial ServicesSEC
ANABAnaptysbio, IncDec 22, 20254:04 PM ETPaul F LizzulOfficer1.50K$75.0KDec 22, 202510b5-1Morgan Stanley Smith Barney LLC Executive Financial ServicesSEC
ANABAnaptysbio, IncDec 22, 20254:01 PM ETDennis MulroyOfficer10.0K$500.0KDec 22, 202510b5-1Morgan Stanley Smith Barney LLC Executive Financial ServicesSEC
ANABAnaptysbio, IncDec 18, 20254:11 PM ETEric J LoumeauOfficer141$6.63KDec 18, 202510b5-1Morgan Stanley Smith Barney LLC Executive Financial ServicesSEC
ANABAnaptysbio, IncDec 17, 20254:12 PM ETEric J LoumeauOfficer10.0K$460.0KDec 17, 202510b5-1Morgan Stanley Smith Barney LLC Executive Financial ServicesSEC
ANABAnaptysbio, IncDec 16, 20254:58 PM ETDennis MulroyOfficer15.7K$705.3KDec 16, 202510b5-1Morgan Stanley Smith Barney LLC Executive Financial ServicesSEC
ANABAnaptysbio, IncDec 16, 20254:09 PM ETEric J LoumeauOfficer12.5K$560.8KDec 16, 202510b5-1Morgan Stanley Smith Barney LLC Executive Financial ServicesSEC
ARQTArcutis Biotherapeutics, Inc.Nov 24, 20253:55 PM ETTodd Franklin WatanabeOfficer48.9K$1.49MNov 24, 202510b5-1Merrill LynchSEC
ARQTArcutis Biotherapeutics, Inc.Nov 21, 20254:49 PM ETTodd Franklin WatanabeOfficer1.05K$31.6KNov 21, 202510b5-1Merrill LynchSEC
ARQTArcutis Biotherapeutics, Inc.Nov 3, 20255:47 PM ETTodd Franklin WatanabeOfficer11.5K$285.4KNov 3, 2025Merrill LynchSEC
ARQTArcutis Biotherapeutics, Inc.Oct 28, 20254:06 PM ETTodd F watanabeOfficer40.0K$1.00MOct 28, 202510b5-1MerrillSEC